Sarepta Therapeutics Inc (SRPT)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 1,582,880 | 1,092,990 | 793,024 | 604,838 | 476,717 |
| Revenue | US$ in thousands | 1,901,980 | 1,243,340 | 933,013 | 701,887 | 540,099 |
| Gross profit margin | 83.22% | 87.91% | 85.00% | 86.17% | 88.26% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $1,582,880K ÷ $1,901,980K
= 83.22%
The gross profit margin of Sarepta Therapeutics Inc has demonstrated a generally positive trend over the five-year period from December 31, 2020, to December 31, 2024. Starting at an impressive 88.26% in 2020, the margin gradually decreased to 83.22% in 2024, with fluctuations along the way.
Although there was a decline in the gross profit margin in the later years, the company still maintained a high level of profitability relative to its costs of production. This indicates that Sarepta Therapeutics Inc was effectively managing its cost of goods sold during the period under consideration.
It is essential for the company to continuously monitor and analyze the factors contributing to changes in the gross profit margin to ensure sustained profitability and operational efficiency. Overall, the slight fluctuations in the margin suggest that Sarepta Therapeutics Inc may have encountered some challenges in cost management, but has managed to maintain a strong gross profit margin throughout the analyzed period.
Peer comparison
Dec 31, 2024